Document Type : Original Article
Authors
1
Department of Hepatology, Gastroenterology and Infectious Diseases, Suez General Hospital, Ministry of Health, Suez, Egypt
2
Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
3
Department of Tropical Medicine, Faculty of Medicine, Minia University, Minia, Egypt
4
Department of Internal Medicine, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt
Abstract
Background: Coronavirus disease 2019 (COVID-19) is firstly reported in Wuhan, China. Then, it was quickly spread and becomes an epidemic. It is due to infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is highly transmissible with a great risk of mortality. Patients with diabetes mellitus (DM) are more prone to infectious agents like SARS-COV-2.
Aim: The aim of the study is to evaluate the relationship between DM and COVID-19 infection regarding to its severity, mortality, rate of admission, complications, and prognosis.
Patients and methods: A cross sectional study was performed between April 2021 and September 2021 and included 75 patients divided into two groups: Group A (COVID-19 patients with diabetes: n= 25), Group B (COVID-19 patients who developed diabetes: n= 25) and Group C (COVID-19 patients without diabetes: n= 25). Demographics, clinical, laboratory, radiologic, management, complications, and clinical outcomes data were collected and compared between the groups.
Results: Patients with diabetes had a higher complication rate, like respiratory failure, acute cardiac injury. The respiratory failure did not significantly different between groups (it was 20%, 28% and 12% in groups A, B and C, respectively, P = .368). However, acute cardiac injury had been significantly increased in groups A than group B and in A and B than group C. (It was 44%, 20% and 8%, in groups A, B and C, respectively, P= 0.01). The mortality rate was also significantly higher among the A and B than C group (56%, 40% vs 8%, P=0.001).
Conclusion: Diabetes is an independent risk factor for the prognosis of COVID-19. Diabetic patients should be intensely monitored during treatment, especially those who require insulin therapy.
Background: Coronavirus disease 2019 [COVID-19] was first reported in Wuhan, China. It then rapidly spread and became a global epidemic due to infection by severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]. COVID-19 is highly transmissible with a high risk of mortality. Patients with diabetes mellitus [DM] are more susceptible to infectious agents like SARS-CoV-2.
Aim of the work: The aim of the study was to evaluate the relationship between DM and COVID-19 infection regarding severity, mortality, admission rate, complications, and prognosis.
Patients and Methods: A cross-sectional study was performed between April 2021 and September 2021. It included 75 patients divided into three groups: Group A [COVID-19 patients with diabetes, n=25], Group B [COVID-19 patients who developed diabetes, n=25] and Group C [COVID-19 patients without diabetes, n=25]. Demographic, clinical, laboratory, radiologic, management, complication, and clinical outcome data were collected and compared between the groups.
Results: Patients with diabetes had a higher rate of complications like respiratory failure and acute cardiac injury. Respiratory failure was not significantly different between groups [20%, 28% and 12% in groups A, B and C respectively, P=0.368]. However, acute cardiac injury was significantly higher in groups A than B and in A and B than C [[44%, 20% and 8% respectively, P=0.01]. The mortality rate was also significantly higher among groups A and B than C [56%, 40% vs 8%, P=0.001].
Conclusion: Diabetes is an independent risk factor for COVID-19 prognosis. Diabetic patients should be closely monitored during treatment, especially those requiring insulin therapy.
Keywords
Main Subjects
)
View on SCiNiTO